Genetic contribution to microglial activation in schizophrenia
Marja Koskuvi1,2, Elina Pörsti1, Tristen Hewitt1
1Neuroscience Center, University of Helsinki, Helsinki, Finland.
Abstract:
Several lines of evidence indicate the involvement of neuroinflammatory processes in the pathophysiology of schizophrenia (SCZ). Microglia are brain resident immune cells responding toward invading pathogens and injury-related products, and additionally, have a critical role in improving neurogenesis and synaptic functions. Aberrant activation of microglia in SCZ is one of the leading hypotheses for disease pathogenesis, but due to the lack of proper human cell models, the role of microglia in SCZ is not well studied. We used monozygotic twins discordant for SCZ and healthy individuals to generate human induced pluripotent stem cell-derived microglia to assess the transcriptional and functional differences in microglia between healthy controls, affected twins and unaffected twins. The microglia from affected twins had increased expression of several common inflammation-related genes compared to healthy individuals. Microglia from affected twins had also reduced response to interleukin 1 beta (IL1β) treatment, but no significant differences in migration or phagocytotic activity. Ingenuity Pathway Analysis (IPA) showed abnormalities related to extracellular matrix signaling. RNA sequencing predicted downregulation of extracellular matrix structure constituent Gene Ontology (GO) terms and hepatic fibrosis pathway activation that were shared by microglia of both affected and unaffected twins, but the upregulation of major histocompatibility complex (MHC) class II receptors was observed only in affected twin microglia. Also, the microglia of affected twins had heterogeneous response to clozapine, minocycline, and sulforaphane treatments. Overall, despite the increased expression of inflammatory genes, we observed no clear functional signs of hyperactivation in microglia from patients with SCZ. We conclude that microglia of the patients with SCZ have gene expression aberrations related to inflammation response and extracellular matrix without contributing to increased microglial activation.
Insights
Schizophrenia (SCZ) involves neuroinflammation. Microglia from affected twins showed altered gene expression for inflammation and extracellular matrix, but no clear functional hyperactivation, suggesting complex roles in SCZ pathogenesis.
Area of Science:
- Neuroscience
- Immunology
- Genetics
Background:
- Neuroinflammation is implicated in schizophrenia (SCZ) pathophysiology.
- Microglia, brain immune cells, play roles in neurogenesis and synaptic function.
- Aberrant microglial activation is a leading hypothesis in SCZ, but human cell models are lacking.
Purpose of the Study:
- To investigate transcriptional and functional differences in human induced pluripotent stem cell-derived microglia from SCZ patients and healthy individuals.
- To utilize monozygotic twins discordant for SCZ to model disease-specific microglial changes.
- To assess microglial responses to inflammatory stimuli and potential therapeutic agents.
Main Methods:
- Generation of human induced pluripotent stem cell-derived microglia from monozygotic twins discordant for SCZ and healthy controls.
- Transcriptional analysis using RNA sequencing and Ingenuity Pathway Analysis (IPA).
- Functional assays assessing response to interleukin-1 beta (IL1β), migration, phagocytosis, and drug treatments (clozapine, minocycline, sulforaphane).
Main Results:
- Microglia from affected twins exhibited increased expression of inflammation-related genes compared to controls.
- Reduced response to IL1β treatment was observed in affected twin microglia, with no significant differences in migration or phagocytosis.
- IPA revealed abnormalities in extracellular matrix signaling, with shared downregulation of ECM-related GO terms and hepatic fibrosis pathway activation in both affected and unaffected twins. Upregulation of MHC class II receptors was specific to affected twin microglia.
Conclusions:
- Schizophrenia patients' microglia display gene expression aberrations in inflammation and extracellular matrix pathways.
- Despite altered gene expression, clear signs of microglial hyperactivation were not observed.
- These findings suggest complex, non-hyperactivated roles for microglia in SCZ pathophysiology, potentially involving altered signaling pathways.
More Related Videos
06:12Author Spotlight: Induced Microglia-Like Cell Technology to Shed Light on the Role of Microglial Dysfunction in Neuropsychiatric Disorders
Published on: September 6, 2024
09:12Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
Related Concept Videos
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
